Share Print Page
 

PHARMACEUTICALS & BIOTECHNOLOGY

Developing new products and turning them into solid business performers is a long, arduous undertaking. Nixon Peabody is acutely aware of the challenges faced by pharmaceutical companies, and we help meet them by providing comprehensive, integrated legal services across multiple disciplines.

Our attorneys and scientists are engaged, knowledgeable, and determined to help clients protect critical patent rights, solidify financial backing, and establish alliances and agreements that preserve value and enhance competitive strength. We organize our services to address clients’ specific business goals in the areas of:

  • Financing, corporate structure
  • Research and development
  • Intellectual property protection, strategy, and litigation
  • Technology transfer
  • Strategic partnerships and alliances
  • Mergers and acquisitions
  • Product development
  • Products liability litigation
  • Regulatory issues and compliance
  • Marketing, sales, advertising, and distribution
  • Labor and employment
  • Dispute resolution and litigation

Our experience is deep and our reach is broad. We have attorneys and technical staff with advanced credentials in molecular biology, chemistry, and biomedical engineering. We advise starts-ups facing the funding and IP issues that arise in early-stage research, as well as the world’s leading companies facing high-stakes litigation challenges.

Nixon Peabody has significant experience working with universities and health care institutions involved in major clinical trials and pioneering research, and we offer clients strategic contacts with business groups and dealmakers worldwide.

Thought Leadership/Alerts

Press

Media Clips

    • Washington Roundup: Federal Circuit Broadens Hatch-Waxman Safe Harbor
      BioWorld Today | August 7, 2012

      This article recaps a recent U.S. Court of Appeals decision expanding the safe harbor for generic drug makers. Washington, DC, patents counsel Mary Webster is quoted discussing how expanding the safe harbor will affect patent claims.

    . . . Hide Media Clips . . .

    Events

    Pharmaceuticals & Biotechnology